← Back to Search

Emotional Group for Healthy Subjects

N/A
Waitlist Available
Led By Lauren C Daniel, Ph.D.
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial seeks to understand what motivates people to join the National Marrow Donor Program and how different strategies affect sign-up intent.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intention to register
Secondary outcome measures
Mood
Psychosocial and Demographic Correlates of intentions to register

Trial Design

2Treatment groups
Experimental Treatment
Group I: Rational GroupExperimental Treatment1 Intervention
Participants will be randomly assigned to receive an emotional or rational appeal, stratified by sex.
Group II: Emotional GroupExperimental Treatment1 Intervention
Participants will be randomly assigned to receive an emotional or rational appeal, stratified by sex.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Emotional Appeal
2022
N/A
~400
Rational Appeal
2022
N/A
~400

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
63,835 Total Patients Enrolled
Lauren C Daniel, Ph.D.Principal InvestigatorRutgers University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the participation in this clinical experiment require a certain age limit?

"According to the study protocol, only individuals aged between 18 and 35 are eligible for this clinical trial."

Answered by AI

What is the current participant count for this investigation?

"Yes, the clinicaltrials.gov portal states that this trial is actively accepting applications from prospective participants. The study was initially listed on October 10th 2022 and recently updated on October 28th 2022. At present, 400 individuals need to be sourced for this investigation at a single medical centre."

Answered by AI

To what extent is enrollment open to those who wish to join this research endeavor?

"Enrollment into this research project necessitates that participants have healthy subjects and are in the 18-35 age range. Presently, approximately 400 individuals are being sought out to be included."

Answered by AI

Is admission to this clinical experiment currently available?

"Per the information available on clinicaltrials.gov, this study is recruiting patients and was first announced on October 10th 2022 before undergoing a recent update made in late October of that same year."

Answered by AI

Who else is applying?

What state do they live in?
New Jersey
What site did they apply to?
Rutgers University Camden
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Motivations to Transplant Registry Participation
Lauren C. Daniel, Ph.D. 2022. "Motivations to Transplant Registry Participation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05595382.
~159 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top